Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Eur J Med Chem. 2011 Mar 17;46(6):2378–2385. doi: 10.1016/j.ejmech.2011.03.021

Table 4.

Antibacterial activity of 3-phenylaminopyridinium Analogs, 12a-s

graphic file with name nihms-289870-t0006.jpg

Compound IC50 /MIC/MBC (μg/mL)

Entry R Sa MRSA E. Coli M. int.
12a H 0.7/1.3/10 3.4/10/20 7.6>20/>20 2.1/25/2.5
12b o-Cl 0.3/0.6/10 1.1/2.5/10 7.6/>20/>20 2.1/2.5/5.0
12c m-Cl 0.34/0.63/5.0 1.3/2.5/5.0 6.5/>20/>20 2.1/2.5/5.0
12d p-Cl 1.5/3.1/NT NT NT 1.0/1.6/NT
12e o-CF3 0.3/0.3/10 0.6/1.3/5.0 9.1/>20/>20 1.2/3.5/2.5
12f m-CF3 NT 1.5/2.5/5.0 4.5/>20/>20 2.0/2.5/2.5
12g p-CF3 NT 0.9/2.5/2.5 3.5/20/20 1.0/1.3/1.3
12h p-F 0.7/1.3/10 3.0/5.0/20 18/>20/>20 3.2/5.0/10.0
12i o-CH3 0.3/0.6/10 1.0/2.5/10 9.4/>20/>20 1.6/2.5/2.5
12j m-CH3 0.7/1.3/5.0 1.2/2.5/5.0 7.7/>20/>20 1.1/1.3/5.0
12k p-CH3 NT 1.0/2.5/2.5 4.5/20/>20 1.5/2.5/2.5
12l p-C2H5 0.2/3.0/5.0 0.7/1.3/2.5 4.0/20/20 0.6/1.3/5.0
12m p-SCH3 0.3/0.6/5.0 1.0/2.5/2.5 5.2/20/20 1.0/1.3/5.0
12n o-OCH3 0.4/0.6/20 1.2/5.0/20 14/>20/>20 1.9/2.5/2.5
12o m-OCH3 0.8/1.3/20.0 4.8/10/20 NA 3.3/5.0/10
12p p-OCH3 0.3/0.6/10.0 1.9/5.0/10 5.4/>20/>20 1.0/1.3/5.0
12q o-CN 1.3/2.5/10.0 6.4/20/20 NA 3.5/5.0/20
12r m-CN 0.8/1.3/20 3.9/10/10 NA 2.0/2.5/10
12s p-CN 2.5/5.0/20 6.2/10/20 NA 2.8/5.0/5.0
Cryptolepine a 10 ( IC50) 20 ( IC50) NT 15 ( IC50)
Ciprofloxacin 0.07/0.3/0.5 0.07/0.3/0.5 0.005/0.3/0.6 0.3/0.5/>20

Abbreviations: Sa = Staphylococcus aureus, MRSA = Methicillin-resistant Staphylococcus aureus, M. Int. = Mycobacterium intracellulare. NT = Not tested. NA = not active at 20 μg/mL· IC50 = The concentration that affords 50% inhibition of growth, MIC = Minimum inhibitory concentration and is the lowest test concentration that allows no detectable growth; MFC = Minimum bactericidal concentration and is the lowest test concentration that kills the microorganism; TC50 = The concentration that is toxic to 50% of cells. The syntheses and characterization of all compounds in this Table were previously reported [3].

a

Data previously reported [10].